# Clinical AI Shifts From Benchmarks to Peer-Reviewed Trials

Medical AI claims increasingly have to clear prospective peer-reviewed clinical study designs rather than retrospective benchmarks, so expect labs to fund registered trials with named hospital partners and procurement to follow published evidence rather than leaderboards.

- Conviction: 40 / 100 (forming)
- Horizon: Emerging (watchlist)
- Tracking since: 2026-10-26T00:00:00.000Z
- Last updated: 2026-10-26T06:52:20.727Z
- Canonical: https://polylog.news/ai/trends/clinical-ai-moves-from-benchmarks-to-trials
- Publisher: Polylog

## Recent evidence

- [confirms] A Lancet study found Google's AMIE matched physicians' final diagnoses 90% of the time across 98 patient consultations (2026-10-26): A study in The Lancet found Google's AMIE matched physicians' final diagnoses 90% of the time across 98 real patient consultations. Every conversation was monitored live by a board-certified internist, and none met the criteria for stopping it, which is the shift from benchmarks to peer-reviewed prospective evidence this thesis predicts.